Hempstract, Inc. (HPST)
Stock analysis · OTC · Healthcare · Drug Manufacturers - Specialty & Generic
Hempstract, Inc. (HPST) is a publicly traded company in the Healthcare sector. Latest price: $0.03. Market cap $25.55M. Trailing PE -33.33. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.
Get full analysis → Short-Term Analysis →Proprietary Signals
About Hempstract, Inc.
Operating across the United States, Hempstract, Inc. develops and supplies products centered around cannabidiol (CBD) and cannabigerol (CBG). Its catalog features CBD in isolate powder form, alongside various distillate oils. The enterprise adopted the Hempstract, Inc. moniker in November 2020, having previously been known as Riverdale Oil and Gas Corporation. This firm maintains its principal office in Warden, Washington.
Valuation
| P/E (TTM) | -33.33× |
|---|---|
| P/S (TTM) | 0.00× |
| P/B | -25.37× |
| PEG | 0.07× |
| P/FCF (TTM) | -41.56× |
| EV / EBITDA | -47.03× |
| EV / Sales | 0.00× |
| Earnings Yield | -3.05% |
| Free Cash Flow Yield | -2.41% |
Fundamentals
| Enterprise Value | $26.61M |
|---|---|
| Net Income (TTM) | -$779.50K |
| Free Cash Flow (TTM) | -$702.17K |
| Net Debt | $1.06M |
| Working Capital | -$1.35M |
| Gross Margin | 0.00% |
| Operating Margin | 0.00% |
| Net Margin | 0.00% |
| Return on Equity | 125.29% |
| Return on Invested Capital | -110.12% |
Peers
Recent News
- No recent news available.
Related
Browse more tickers: sitemap